Our Mission
GLP-1 Guide is an independent, evidence-based resource dedicated to helping people understand and navigate GLP-1 medications — including Ozempic (semaglutide), Wegovy, Mounjaro (tirzepatide), and emerging treatments.
We believe that anyone considering or currently using GLP-1 medications deserves clear, accurate information — not marketing copy, not forum rumors, but research you can verify.
Our Approach
Every article is built on three principles:
- Cite real research: We link directly to PubMed-indexed studies so you can check every claim yourself. No vague “studies show” — every reference has a clickable PMID.
- Stay current: We monitor new clinical trials, FDA updates, and treatment guidelines (ADA, AACE, Endocrine Society) and update affected articles when the evidence changes.
- No pharma influence: We do not accept payment from pharmaceutical companies for content. Our recommendations are based on published evidence, not sponsorship.
What We Cover
- Medication Guides: How GLP-1 drugs work, dosing schedules, administration tips, and what to expect at each stage
- Side Effects: Honest, research-backed information on common side effects (nausea, GI issues) and less common ones — including management strategies
- Diet & Lifestyle: Meal plans, exercise routines, and supplement guidance optimized for people on GLP-1 medications
- Research Updates: Plain-English summaries of the latest clinical trials, meta-analyses, and real-world evidence
- Head-to-Head Comparisons: Ozempic vs Wegovy, Mounjaro vs Ozempic, and more — based on trial data, not marketing
Medical Disclaimer
The information on GLP-1 Guide is for educational purposes only. It is not medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Read our full Medical Disclaimer.
Contact Us
Have a question, correction, or suggestion? We respond to every message.
Email: [email protected]
Want to verify a citation? Every article includes clickable PMID links to the original PubMed studies.
Last updated: June 15, 2026